The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

QY Research Reports

SynopsisCarfilzomib is an epoxomicin derivate with potential antineoplastic activity. Carfilzomib irreversibly binds to and inhibits the chymotrypsin-like activity of the 20S catalytic core subunit of the proteasome, a protease complex responsible for degrading a larg.....

No Of Pages : 90
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisDasatinib is a selective tyrosine kinase receptor inhibitor that is used in the therapy of chronic myelogenous leukemia (CML) positive for the Philadelphia chromosome. Dasatinib is commonly associated with transient elevations in serum aminotransferase levels .....

No Of Pages : 85
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisDecitabine is a cytosine analogue and an intravenously administered antineoplastic agent used in the therapy of myelodysplastic syndromes. Decitabine is associated with a low rate of transient serum enzyme elevations during therapy, but has not been implicated.....

No Of Pages : 100
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisEnzalutamide is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, enzalutamide inh.....

No Of Pages : 87
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisDivalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures. Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-depressive ill.....

No Of Pages : 86
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisDutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland. The global Dutasteride API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CA.....

No Of Pages : 103
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisEdaravone is a free radical scavenger approved in May, 2017 for the treatment of amyotrophic lateral scleorosis (ALS). Clinical studies showed that the treatment attenuated deterioration of the disease when compared to placebo. It has been previously investiga.....

No Of Pages : 88
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisEnalapril Maleate is the maleate salt form of enalapril, a dicarbocyl-containing peptide and angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, enalapril is converted by de-esterification into its active form enalaprila.....

No Of Pages : 96
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisEribulin Mesylate is the mesylate salt of a synthetic analogue of halichondrin B, a substance derived from a marine sponge (Lissodendoryx sp.) with antineoplastic activity. Eribulin binds to the vinca domain of tubulin and inhibits the polymerization of tubuli.....

No Of Pages : 89
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisEszopiclone is a nonbenzodiazepine, cyclopyrrolone and active stereoisomer of zopiclone with hypnotic and sedative activity and without significant anxiolytic activity. Although the exact mechanism of action remains to be fully elucidated, eszopiclone is able .....

No Of Pages : 92
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00